Total Payments
$1.1M
2024 Payments
$49,570
Companies
23
Transactions
1,303
Payment Breakdown by Category
Other$888,693 (79.4%)
Consulting$109,917 (9.8%)
Travel$104,549 (9.3%)
Food & Beverage$16,324 (1.5%)
Education$383.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $884,133 | 309 | 78.9% |
| Consulting Fee | $109,917 | 43 | 9.8% |
| Travel and Lodging | $104,549 | 516 | 9.3% |
| Food and Beverage | $16,324 | 425 | 1.5% |
| Honoraria | $4,560 | 1 | 0.4% |
| Education | $383.40 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $398,753 | 455 | $0 (2023) |
| EMD Serono, Inc. | $381,039 | 417 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $66,694 | 74 | $0 (2018) |
| Genentech USA, Inc. | $54,515 | 44 | $0 (2022) |
| Biogen, Inc. | $48,089 | 94 | $0 (2023) |
| Acorda Therapeutics, Inc | $43,601 | 37 | $0 (2021) |
| Celgene Corporation | $27,617 | 57 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $21,373 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $19,213 | 20 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $17,148 | 20 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,570 | 25 | EMD Serono, Inc. ($49,512) |
| 2023 | $92,250 | 110 | EMD Serono, Inc. ($63,606) |
| 2022 | $143,548 | 153 | EMD Serono, Inc. ($57,083) |
| 2021 | $88,905 | 98 | Genentech USA, Inc. ($22,531) |
| 2020 | $57,972 | 93 | EMD Serono, Inc. ($29,821) |
| 2019 | $205,234 | 261 | GENZYME CORPORATION ($87,438) |
| 2018 | $210,400 | 231 | GENZYME CORPORATION ($129,160) |
| 2017 | $271,987 | 332 | GENZYME CORPORATION ($133,927) |
All Payment Transactions
1,303 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,555.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $352.42 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $44.61 | General |
| Category: Neurology | ||||||
| 09/25/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,935.00 | General |
| Category: Neurology | ||||||
| 09/25/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,795.00 | General |
| Category: Neurology | ||||||
| 09/25/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,795.00 | General |
| Category: Neurology | ||||||
| 08/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $1,451.17 | General |
| Category: Neurology | ||||||
| 08/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $367.65 | General |
| Category: Neurology | ||||||
| 08/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $32.16 | General |
| Category: Neurology | ||||||
| 08/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,795.00 | General |
| Category: Neurology | ||||||
| 07/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,243.00 | General |
| Category: Neurology | ||||||
| 04/25/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $34.87 | General |
| 03/25/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $21.44 | General |
| Category: Neurology | ||||||
| 03/22/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Immunology | ||||||
| 03/20/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,795.00 | General |
| Category: Neurology | ||||||
| 02/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.70 | General |
| 02/20/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,795.00 | General |
| Category: Neurology | ||||||
| 02/20/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| Category: Neurology | ||||||
| 02/16/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $14.74 | General |
| Category: Neurology | ||||||
| 01/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $41.63 | General |
| Category: Neuroscience | ||||||
| 01/22/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,175.00 | General |
| 01/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,415.00 | General |
| Category: Neurology | ||||||
| 01/22/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| 01/11/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $345.00 | General |
| 01/02/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $93.01 | General |
About Dr. Allen Bowling, MD
Dr. Allen Bowling, MD is a Specialist healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790778744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Bowling, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $49,570 received in 2024. These payments were reported across 1,303 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($884,133).
Ad
Practice Information
- Specialty Specialist
- Location Englewood, CO
- Active Since 08/24/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1790778744
Products in Payments
- AUBAGIO (Drug) $316,856
- Mavenclad (Drug) $137,466
- Rebif (Biological) $91,262
- Mavenclad (Biological) $71,339
- COPAXONE (Drug) $66,567
- LEMTRADA (Drug) $58,160
- OCREVUS (Biological) $54,515
- AMPYRA (Drug) $43,601
- ZEPOSIA (Drug) $39,720
- MAVENCLAD (Drug) $38,399
- VUMERITY (Drug) $25,605
- ACTHAR (Biological) $19,427
- TYSABRI (Biological) $17,981
- MAYZENT (Drug) $9,868
- Ozanimod (Drug) $9,270
- BRIUMVI (Drug) $8,445
- Evobrutinib $6,950
- BAFIERTAM (Drug) $5,658
- DISEASE STATE (Drug) $2,918
- Ponvory (Drug) $1,695
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Englewood
Mr. Wayne Yakes, M.d, M.D
Specialist — Payments: $1.4M
Specialist $1.4M
Steven Elias, Md, MD
Specialist — Payments: $650,903
Specialist $650,903
Dr. Richard D'amico, M.d, M.D
Specialist — Payments: $539,807
Specialist $539,807
Dr. Judy Lane, Md, MD
Specialist — Payments: $475,377
Specialist $475,377
Kirsten Bracht, Md, MD
Specialist — Payments: $156,546
Specialist $156,546
Dr. Nicolas Slenkovich, Md, MD
Specialist — Payments: $20,152
Specialist $20,152